Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Jun 6, 2025

Accession no.
0001628280-25-029849
Filed
Jun 6, 2025
Trade date
May 1-30, 2025
Filing delay
36 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $857.68. It was filed 36 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2025Common StockPPurchaseAcquired+8$4.86+$38.885,699,100Direct
May 2, 2025Common StockPPurchaseAcquired+8$4.75+$385,699,108Direct
May 5, 2025Common StockPPurchaseAcquired+8$4.68+$37.445,699,116Direct
May 6, 2025Common StockPPurchaseAcquired+8$4.60+$36.85,699,124Direct
May 7, 2025Common StockPPurchaseAcquired+8$4.71+$37.685,699,132Direct
May 8, 2025Common StockPPurchaseAcquired+8$4.50+$365,699,140Direct
May 9, 2025Common StockPPurchaseAcquired+8$4.78+$38.245,699,148Direct
May 12, 2025Common StockPPurchaseAcquired+8$5.25+$425,699,156Direct
May 13, 2025Common StockPPurchaseAcquired+8$5.67+$45.365,699,164Direct
May 14, 2025Common StockPPurchaseAcquired+8$5.68+$45.445,699,172Direct
May 15, 2025Common StockPPurchaseAcquired+8$5.20+$41.65,699,180Direct
May 16, 2025Common StockPPurchaseAcquired+8$5.37+$42.965,699,188Direct
May 19, 2025Common StockPPurchaseAcquired+8$4.92+$39.365,699,196Direct
May 20, 2025Common StockPPurchaseAcquired+8$5.41+$43.285,699,204Direct
May 21, 2025Common StockPPurchaseAcquired+8$5.05+$40.45,699,212Direct
May 22, 2025Common StockPPurchaseAcquired+8$5.10+$40.85,699,220Direct
May 23, 2025Common StockPPurchaseAcquired+8$5.14+$41.125,699,228Direct
May 27, 2025Common StockPPurchaseAcquired+8$5.27+$42.165,699,236Direct
May 28, 2025Common StockPPurchaseAcquired+8$5.68+$45.445,699,244Direct
May 29, 2025Common StockPPurchaseAcquired+8$5.66+$45.285,699,252Direct
May 30, 2025Common StockPPurchaseAcquired+8$4.93+$39.445,699,260Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)